CO6511241A2 - Régimen de inmunizaión por sensibilización-refuerzo heteróloga - Google Patents
Régimen de inmunizaión por sensibilización-refuerzo heterólogaInfo
- Publication number
- CO6511241A2 CO6511241A2 CO12044534A CO12044534A CO6511241A2 CO 6511241 A2 CO6511241 A2 CO 6511241A2 CO 12044534 A CO12044534 A CO 12044534A CO 12044534 A CO12044534 A CO 12044534A CO 6511241 A2 CO6511241 A2 CO 6511241A2
- Authority
- CO
- Colombia
- Prior art keywords
- heterological
- awareness
- reinforcement
- immunization scheme
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La invención proporciona procedimientos para inducir una respuesta inmune específica de antígeno en un sujeto mediante el uso de una combinación de composiciones inmunogénicas. Generalmente, el procedimiento implica la administración al sujeto de una cantidad eficaz de dos composiciones inmunogénicas diferentes, comprendiendo ambas serotipo 8 del virus de la lengua azul.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23912509P | 2009-09-02 | 2009-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6511241A2 true CO6511241A2 (es) | 2012-08-31 |
Family
ID=42829427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO12044534A CO6511241A2 (es) | 2009-09-02 | 2012-03-14 | Régimen de inmunizaión por sensibilización-refuerzo heteróloga |
Country Status (17)
Country | Link |
---|---|
US (1) | US20110110980A1 (es) |
EP (1) | EP2473190A1 (es) |
JP (1) | JP2013503869A (es) |
KR (1) | KR20120062853A (es) |
CN (1) | CN102481358A (es) |
AR (1) | AR078147A1 (es) |
AU (1) | AU2010289734A1 (es) |
BR (1) | BR112012004703A2 (es) |
CA (1) | CA2770070A1 (es) |
CL (1) | CL2012000580A1 (es) |
CO (1) | CO6511241A2 (es) |
MX (1) | MX2012002630A (es) |
RU (1) | RU2012107823A (es) |
TW (1) | TW201125579A (es) |
UY (1) | UY32876A (es) |
WO (1) | WO2011028652A1 (es) |
ZA (1) | ZA201200892B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103305471B (zh) * | 2013-06-18 | 2014-11-05 | 中国农业科学院哈尔滨兽医研究所 | 抗蓝舌病病毒血清8型vp2蛋白的单克隆抗体btv8-vp2-4d9及其识别的b细胞表位多肽和应用 |
CN112870346A (zh) * | 2021-01-21 | 2021-06-01 | 云南省畜牧兽医科学院 | 一种蓝舌病病毒二价灭活疫苗的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
US4567042A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
US5057540A (en) * | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
CA1331443C (en) | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
BE1008978A5 (fr) * | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
GB9622159D0 (en) * | 1996-10-24 | 1996-12-18 | Solvay Sociutu Anonyme | Polyanionic polymers as adjuvants for mucosal immunization |
WO1998056415A1 (en) | 1997-06-11 | 1998-12-17 | Aquila Biopharmaceuticals, Inc. | Purified saponins as oral adjuvants |
US6645495B1 (en) | 1997-08-29 | 2003-11-11 | Antigenics, Inc. | Compositions of saponin adjuvants and excipients |
US7862821B2 (en) * | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
-
2010
- 2010-08-27 US US12/869,832 patent/US20110110980A1/en not_active Abandoned
- 2010-08-30 JP JP2012527945A patent/JP2013503869A/ja active Pending
- 2010-08-30 BR BR112012004703A patent/BR112012004703A2/pt not_active IP Right Cessation
- 2010-08-30 WO PCT/US2010/047096 patent/WO2011028652A1/en active Application Filing
- 2010-08-30 AU AU2010289734A patent/AU2010289734A1/en not_active Abandoned
- 2010-08-30 RU RU2012107823/15A patent/RU2012107823A/ru unknown
- 2010-08-30 EP EP10752232A patent/EP2473190A1/en not_active Withdrawn
- 2010-08-30 CA CA2770070A patent/CA2770070A1/en not_active Abandoned
- 2010-08-30 CN CN2010800390498A patent/CN102481358A/zh active Pending
- 2010-08-30 MX MX2012002630A patent/MX2012002630A/es not_active Application Discontinuation
- 2010-08-30 KR KR1020127008284A patent/KR20120062853A/ko not_active Application Discontinuation
- 2010-09-01 AR ARP100103199A patent/AR078147A1/es not_active Application Discontinuation
- 2010-09-02 TW TW099129676A patent/TW201125579A/zh unknown
- 2010-09-02 UY UY0001032876A patent/UY32876A/es not_active Application Discontinuation
-
2012
- 2012-02-06 ZA ZA2012/00892A patent/ZA201200892B/en unknown
- 2012-03-02 CL CL2012000580A patent/CL2012000580A1/es unknown
- 2012-03-14 CO CO12044534A patent/CO6511241A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CL2012000580A1 (es) | 2012-07-13 |
MX2012002630A (es) | 2012-05-08 |
AU2010289734A1 (en) | 2012-03-01 |
JP2013503869A (ja) | 2013-02-04 |
ZA201200892B (en) | 2012-10-31 |
EP2473190A1 (en) | 2012-07-11 |
TW201125579A (en) | 2011-08-01 |
US20110110980A1 (en) | 2011-05-12 |
AR078147A1 (es) | 2011-10-19 |
BR112012004703A2 (pt) | 2016-04-12 |
RU2012107823A (ru) | 2013-10-10 |
UY32876A (es) | 2011-04-29 |
CN102481358A (zh) | 2012-05-30 |
CA2770070A1 (en) | 2011-03-10 |
WO2011028652A1 (en) | 2011-03-10 |
KR20120062853A (ko) | 2012-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018000319A1 (es) | Coadyuvantes basados en aceite (divisional de solicitud 201600650) | |
BR112018004242A2 (pt) | composições de vacina que possuem estabilidade e imunogenicidade aumentadas | |
EA201100268A1 (ru) | Вакцина | |
CO6382137A2 (es) | Oligonucleótidos inmunoestimuladores | |
EA201291105A1 (ru) | Пероральная вакцина, содержащая антиген и агонист toll-подобного рецептора | |
EA201291157A1 (ru) | Мультивалентные вакцины с синтетическими наноносителями | |
IN2012DN02736A (es) | ||
CO6331297A2 (es) | Composiciones adyuvantes novedosas | |
EA201291117A1 (ru) | Иммуногенные композиции и способы лечения неоплазии | |
CR20120310A (es) | Anticuerpos neutralizadores contra el receptor de prolactina y su uso terapéutico | |
EA201691348A1 (ru) | Однофлаконные вакцинные составы | |
MX2013010620A (es) | Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo. | |
MX2015007753A (es) | Composicion de vacunas para sujetos intactos. | |
TR201802380T4 (tr) | Benzonaftiridin içeren aşılar. | |
PH12015501637A1 (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant | |
NZ729519A (en) | Methods and compositions for intra-nasal immunization with recombinant mva encoding flagellin | |
AR061894A1 (es) | Vacunas para malaria | |
BR112015004515A2 (pt) | composição imunogênica | |
WO2011106607A3 (en) | Subunit vaccines for herpes viruses and methods of use | |
CL2017001961A1 (es) | Vacuna bivalente contra el virus de gripe porcina | |
PH12018000197A1 (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
BRPI1007721B1 (pt) | composição de vacina para uso na indução de uma resposta imunológica contra um rotavírus em um indivíduo, cepa de rotavírus isolado de cdc-9 e cepa de rotavírus isolado de cdc-66 | |
AR080111A1 (es) | Metodos y composiciones de inmunizacion | |
EA201290956A1 (ru) | Вакцина против вич | |
BR112015022582A2 (pt) | molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |